Biggest stock movers today: Tesla, AstraZeneca, Netlist and more
Fahroni/iStock via Getty Images
Stock futures were mixed during Monday's session as traders prepare for a holiday-shortened session before the fourth of July.
Here are some of Monday's biggest gainers and losers:
Biggest stock gainers

Fidelity National Information Services (NYSE:FIS) shares climbed about 8% following a report that private equity companies, including Advent, are considering buying the company's majority ownership in Worldpay for more than $15 billion. The report comes after Fidelity National (FIS) announced in February that it planned to spin off its Merchant Solutions business, known as Worldpay. Fidelity National purchased Worldpay for about $35 billion in 2019.

Shares of electric vehicle (EV) makers experienced significant gains during the premarket session on Monday, driven by a substantial increase in vehicle deliveries throughout June:
Tesla (NASDAQ:TSLA) stock jumped about 6% after its June deliveries grew 83% Y/Y to 466,140 vehicles, surpassing expectation of 445,000 units. The company produced 479,700 vehicles during the month of June.
Nio (NYSE:NIO) shares were up around 7% due to a sequential improvement of 74% in June deliveries. The company delivered 10,707 vehicles in June 2023, down 17.4% Y/Y.
XPeng (NYSE:XPEV) stock rose more than 10% after June deliveries saw growth of 15% M/M to 8,620 Smart EVs. However, these deliveries showed a Y/Y decrease of 43%.
Li Auto (NASDAQ:LI) shares surged nearly 7% after the company announced June deliveries of 32,575 vehicles, up 150.1% Y/Y. For Q3, the company projects monthly deliveries for Li L8 and Li L9 at over 10,000 each and aims to achieve 15,000 Li L7 monthly deliveries. In Q4, the company aims to achieve the 40,000 monthly deliveries.

Biggest stock losers

Netlist (OTCQB:NLST) stock fell more than 13% after losing a request in a patent validity investigation with the United States Patent and Trademark Office that argued Google (GOOGL) was a party in a patent dispute with Samsung Electronics (OTCPK:SSNLF).
AstraZeneca (NASDAQ:AZN) shares plunged about 7% after it announced preliminary results for a phase three trial of a lung cancer treatment. The results for the dual primary endpoint of overall survival (OS) were not mature, and an early trend in favour of datopotamab deruxtecan against docetaxel was noted, but it did not satisfy the prespecified statistical significance level at this interim analysis. The trial will proceed as planned in order to assess OS with greater maturity. The results will be hidden from the investigators and participants.
Bright Health Group (NYSE:BHG) shares slumped about 6% after it agreed to sell its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare (MOH) for $600 million.

More on markets

Nasdaq futures lead S&P, Dow; yields keep rising on shortened trading day
The Stock Market: No Bear Market Now
The Fed Finds That 37% Of U.S. Firms Are Close To Default